considerations in demonstrating complex api sameness (7of39) complex generics 2018
Published 4 years ago • 3.3K plays • Length 16:13Download video MP4
Download video MP3
Similar videos
-
24:21
regulatory considerations in demonstrating complex api sameness
-
19:36
strategies to demonstrate complex api sameness (10of35) complex generics – sep. 25-26, 2019
-
9:20
considerations for establishing q1/q2 sameness of complex formulations (10of39) complex generics '18
-
15:59
overview of current science-based regulatory standards (21of39) complex generics 2018
-
25:59
questions and panel discussion (16of39) complex generics 2018
-
19:35
questions and panel discussion (9of39) complex generics 2018
-
20:56
pre-anda program overview (2of39) complex generics 2018
-
46:47
pre-anda logistics and best practices (3of39) complex generics 2018
-
18:37
questions and panel discussion (20of39) complex generics 2018
-
20:57
common issues in complex drug substance review (8of39) complex generics 2018
-
24:52
questions and panel discussion (5of39) complex generics 2018
-
20:51
strategies to demonstrate complex excipient sameness (15of35) complex generics – sep. 25-26, 2019
-
15:39
office of generic drugs keynote (1of39) complex generics 2018
-
35:01
combination products: user-interface & role of comparative analyses (29of39) complex generics 2018
-
18:45
iron colloid drug products: characterization and impurity (13of39) complex generics 2018
-
18:05
peptide drug challenges through pre-anda processes & case studies (6of39) complex generics 2018
-
19:39
strategies for generic topical product development (7of35) complex generics– sep. 25-26, 2019
-
35:57
questions and answers (4of35) complex generics – sep. 25-26, 2019
-
17:27
pre-anda review: office of pharmaceutical quality (opq) (4of39) complex generics 2018